These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28345006)

  • 1. Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification.
    Knipping F; Osborn MJ; Petri K; Tolar J; Glimm H; von Kalle C; Schmidt M; Gabriel R
    Mol Ther Methods Clin Dev; 2017 Mar; 4():213-224. PubMed ID: 28345006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases.
    Chu C; Yang Z; Yang J; Yan L; Si C; Kang Y; Chen Z; Chen Y; Ji W; Niu Y
    BMC Biotechnol; 2019 Jan; 19(1):7. PubMed ID: 30646876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.
    Basu S; Aryan A; Overcash JM; Samuel GH; Anderson MA; Dahlem TJ; Myles KM; Adelman ZN
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4038-43. PubMed ID: 25775608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293FT cells.
    He Z; Proudfoot C; Whitelaw CB; Lillico SG
    Springerplus; 2016; 5(1):814. PubMed ID: 27390654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
    Cottle RN; Lee CM; Archer D; Bao G
    Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus).
    Aluru N; Karchner SI; Franks DG; Nacci D; Champlin D; Hahn ME
    Aquat Toxicol; 2015 Jan; 158():192-201. PubMed ID: 25481785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene.
    Nerys-Junior A; Braga-Dias LP; Pezzuto P; Cotta-de-Almeida V; Tanuri A
    Genet Mol Biol; 2018; 41(1):167-179. PubMed ID: 29583154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
    Auer TO; Del Bene F
    Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology-Independent Integration of Plasmid DNA into the Zebrafish Genome.
    Auer TO; Del Bene F
    Methods Mol Biol; 2016; 1451():31-51. PubMed ID: 27464799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP.
    Houghton BC; Panchal N; Haas SA; Chmielewski KO; Hildenbeutel M; Whittaker T; Mussolino C; Cathomen T; Thrasher AJ; Booth C
    Front Genome Ed; 2022; 4():828489. PubMed ID: 35677600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of microhomologous-mediated site-specific integrated LacS gene cow using TALENs.
    Su X; Wang S; Su G; Zheng Z; Zhang J; Ma Y; Liu Z; Zhou H; Zhang Y; Zhang L
    Theriogenology; 2018 Oct; 119():282-288. PubMed ID: 30075414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.